Biohaven Ltd.
BHVN
$15.00
$0.281.90%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.19% | 10.32% | 16.08% | 12.47% | 10.61% |
| Total Depreciation and Amortization | -4.52% | -8.05% | -17.66% | 57.99% | -11.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.27% | 41.43% | -19.80% | 185.41% | -83.51% |
| Change in Net Operating Assets | 131.41% | -440.16% | -226.30% | -116.22% | 525.15% |
| Cash from Operations | 43.24% | -14.74% | 10.33% | 13.23% | -1.70% |
| Capital Expenditure | -- | -- | 38.46% | 94.42% | 49.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 197.63% | 210.79% | -108.32% | 1,177.39% | -109.26% |
| Cash from Investing | 194.65% | 210.72% | -108.33% | 1,161.15% | -109.43% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.88% | -5.50% | 155,178.69% | -88.67% | 191.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -97.88% | -5.18% | 154,650.82% | -99.95% | 67,604.61% |
| Foreign Exchange rate Adjustments | -81.25% | -- | -100.00% | 135.00% | -273.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.29% | -0.16% | 128.99% | -70.76% | 45,007.48% |